JP2012505227A5 - - Google Patents

Download PDF

Info

Publication number
JP2012505227A5
JP2012505227A5 JP2011531146A JP2011531146A JP2012505227A5 JP 2012505227 A5 JP2012505227 A5 JP 2012505227A5 JP 2011531146 A JP2011531146 A JP 2011531146A JP 2011531146 A JP2011531146 A JP 2011531146A JP 2012505227 A5 JP2012505227 A5 JP 2012505227A5
Authority
JP
Japan
Prior art keywords
antibody
agent
antagonist
osteoporosis
produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011531146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012505227A (ja
JP5860699B2 (ja
Filing date
Publication date
Priority claimed from US12/246,715 external-priority patent/US7837994B2/en
Application filed filed Critical
Priority claimed from PCT/US2009/059865 external-priority patent/WO2010042634A1/en
Publication of JP2012505227A publication Critical patent/JP2012505227A/ja
Publication of JP2012505227A5 publication Critical patent/JP2012505227A5/ja
Application granted granted Critical
Publication of JP5860699B2 publication Critical patent/JP5860699B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011531146A 2008-10-07 2009-10-07 骨粗鬆症の治療のためのｉｌ−２０アンタゴニストの使用 Expired - Fee Related JP5860699B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12/246,715 US7837994B2 (en) 2008-10-07 2008-10-07 Use of anti-IL-20 antibody for treating osteoporosis
US12/246,715 2008-10-07
US23866109P 2009-08-31 2009-08-31
US61/238,661 2009-08-31
PCT/US2009/059865 WO2010042634A1 (en) 2008-10-07 2009-10-07 Use of il-20 antagonists for treating rheumatoid arthritis and osteoporosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015214727A Division JP2016041730A (ja) 2008-10-07 2015-10-30 リウマチ性関節炎の治療のためのｉｌ−２０アンタゴニストの使用

Publications (3)

Publication Number Publication Date
JP2012505227A JP2012505227A (ja) 2012-03-01
JP2012505227A5 true JP2012505227A5 (https=) 2012-11-22
JP5860699B2 JP5860699B2 (ja) 2016-02-16

Family

ID=42100943

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011531146A Expired - Fee Related JP5860699B2 (ja) 2008-10-07 2009-10-07 骨粗鬆症の治療のためのｉｌ−２０アンタゴニストの使用
JP2015214727A Pending JP2016041730A (ja) 2008-10-07 2015-10-30 リウマチ性関節炎の治療のためのｉｌ−２０アンタゴニストの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015214727A Pending JP2016041730A (ja) 2008-10-07 2015-10-30 リウマチ性関節炎の治療のためのｉｌ−２０アンタゴニストの使用

Country Status (7)

Country Link
EP (1) EP2340039B1 (https=)
JP (2) JP5860699B2 (https=)
KR (1) KR101691534B1 (https=)
CN (1) CN102281898B (https=)
CA (1) CA2739794A1 (https=)
DK (1) DK2340039T3 (https=)
WO (1) WO2010042634A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013525307A (ja) * 2010-04-16 2013-06-20 ナショナル チェン クン ユニバーシティ Ｉｌ−２０受容体活性の遮断による、ｉｌ−２０受容体を介するシグナリング経路に関連する障害の治療
WO2014006230A1 (en) 2012-07-06 2014-01-09 Novo Nordisk A/S Il-20 epitopes and il-20 ligands
CA2878825A1 (en) * 2012-07-10 2014-01-16 The Uab Research Foundation Compositions and methods for modulation of il-20 family cytokine activity
US8603470B1 (en) * 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
US9376490B2 (en) * 2014-04-01 2016-06-28 National Cheng Kung University Treatment of inflammatory pain using IL-20 antagonists
WO2016083304A1 (en) * 2014-11-24 2016-06-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Treatment of acute exacerbations of chronic obstructive pulmonary disease by antagonism of the il-20r.
US9982043B2 (en) 2016-06-03 2018-05-29 National Cheng Kung University Use of IL-20 antagonists for treating pancreatic cancer
KR101796025B1 (ko) 2017-04-25 2017-11-10 가톨릭대학교 산학협력단 사포그릴레이트, 프라바스타틴 및 tnf-억제제를 유효성분으로 포함하는 죽상동맥경화증 예방 또는 치료용 약학조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0929578T3 (da) * 1996-02-09 2003-08-25 Abbott Lab Bermuda Ltd Humane antistoffer, der binder human TNFalfa
US6649779B2 (en) * 1997-05-02 2003-11-18 Wyeth Estrenes
CN1247780C (zh) * 1997-11-26 2006-03-29 津莫吉尼蒂克斯公司 哺乳动物细胞因子样多肽－10
US20030148955A1 (en) * 1999-04-19 2003-08-07 Pluenneke John D. Soluble tumor necrosis factor receptor treatment of medical disorders
JP4741139B2 (ja) * 1999-12-23 2011-08-03 ザイモジェネティクス， インコーポレイテッド 可溶性インターロイキン−２０レセプター
WO2001046261A1 (en) * 1999-12-23 2001-06-28 Zymogenetics, Inc. Method for treating inflammation
US7122632B2 (en) * 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
US6610286B2 (en) * 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
US20050143333A1 (en) * 2001-05-18 2005-06-30 Sirna Therapeutics, Inc. RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
CA2459943A1 (en) * 2001-09-21 2003-04-03 Merck & Co., Inc. Androstanes as androgen receptor modulators
JP2005511593A (ja) * 2001-11-08 2005-04-28 メルク　エンド　カムパニー　インコーポレーテッド 骨粗鬆症を治療するための組成物及び方法
US7435800B2 (en) * 2003-05-23 2008-10-14 Chi-Mei Medical Center Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation
DE602004023965D1 (de) * 2003-11-21 2009-12-17 Zymogenetics Inc Anti-il-20-antikörper und bindungspartner und verfahren zur anwendung bei entzündungen
US8097685B2 (en) * 2006-03-30 2012-01-17 Toray Industries, Inc. Dendritic polymer, method for producing the same, and thermoplastic resin composition
WO2008016134A1 (fr) * 2006-08-04 2008-02-07 Norihiro Nishimoto PROCÉDÉ POUR PRÉDIRE LE PRONOSTIC DES PATIENTS ATTEINTS DE POLYARTHRITE rhumatoïde

Similar Documents

Publication Publication Date Title
JP2012505227A5 (https=)
US8426562B2 (en) Methods and compositions for modulating tumor cell activity
JP2018506961A5 (https=)
JP2017149720A5 (https=)
JP2009529920A5 (https=)
US20220041721A1 (en) Cd3 antigen binding fragment and application thereof
JP2020504076A5 (https=)
JP2017535257A5 (https=)
JP2018519364A5 (https=)
RU2018108048A (ru) Новые анти-pd-1 антитела
JP2012012402A5 (https=)
JPWO2019129221A5 (https=)
JP2012525854A5 (https=)
JP2013519367A5 (https=)
JP2007510664A5 (https=)
JP2019512523A5 (https=)
JP2007526908A5 (https=)
JP2021520201A5 (https=)
TW202300527A (zh) 使用ｇｒｅｍ１拮抗劑治療疾病的方法
CN120712286A (zh) 抗体、抗原结合片段和使用方法
CN114729036A (zh) 抗干细胞因子抗体及其使用方法
CN116284426A (zh) 一种抗gucy2c/cd3双特异性抗体及其用途
WO2019230869A1 (ja) 抗ヒトｔｌｒ７抗体
WO2019172165A1 (ja) 異所性骨化の治療又は予防のための医薬組成物
CN112805297B (zh) 抗人类pd-l1抗体及其用途